EXOCRINE AND ENDOCRINE PANCREATIC INSUFFICIENCY IN DEVELOPMENT OF ATHEROSCLEROSIS
PDF

Keywords

chronic pancreatitis type 2 diabetes mellitus, atherosclerosis, carotid intima media thickness.

Abstract

Objective: To evaluate the effect of chronic pancreatitis (CP) and exocrine insufficiency of the pancreas on the carotid intima media thickness (cIMT) in patients with type 2 diabetes mellitus (DM-2). 

Materials and methods: 91 patients were examined, they were divided into groups: 1st group-patients with DM-2 (n = 31) group 2nd – DM-2 combined with CP (n = 60).  Fasting plasma glucose (FPG), HbA1c, immunoreactive insulin (IRI), HOMA-IR index, C-reactive protein (CRP), serum α-amylase and fecal-1 elastase (FE-1) were assessed.  In order to assess the thickness of the cIMT, ultrasound of the common carotid artery was performed.  The control group of healthy volunteers was representative by age and sex. 

Results: In the 1st and 2nd groups, the average value of cIMT was (1.02 ± 0.1 vs 1.21 ± 0.15) mm.  Parameters of DM-2 management in the 1st and 2nd groups were (FPG 8.18 ± 0.92vs8.57 ± 1.2) mmol / l;  HbA1c (7.23 ± 0.21vs7.49 ± 0.36)%;  IRI (20.31 ± 0.9vs22.53 ± 1.2) μIU / ml;  HOMA-IR (6.55 ± 1.5vs8.38 ± 2.2) μIU / ml * mmol / l;  PSA (1.3 ± 0.12vs6.77 ± 0.31).  HOMA-IR correlated with: CRP (r = 0.43, p <0.05 in group 1; r = 0.61, p <0.05 in group 2);  FE-1 (r = -0.55, p <0.05 of the 2nd group);  and cIMT (r = 0.42, p <0.05 in the 1st group; r = 0.53, p <0.05 in the 2nd group).  IRI have relationship with: FE-1 (r = 0.41, p <0.05 in group 1; r = -0.3, p <0.05 in group 2);  CRP (r = 0.42, p <0.05 in group 1; r = -0.28, p <0.05 in group 2); HbA1c had close relationships with cIMT (r = 0.38, p <0.05 in group 1; r = 0.51, p <0.05 in group 2).  The relationship between cIMT and CRP was related in the 2nd group (r = 0.39, p <0.05);  with α-amylase (r = 0.2, p <0.01 2nd group).  There was no significant relationship between cIMT and FE-1 in the study. 

Conclusions: Obtained data allows us to conclude that hyperinsulinemia and insulin resistance have a direct atherogenic effect on the walls of blood vessels.  It is established that the accession of the inflammatory process leads to increasing development of atherosclerotic lesions of the vessel, at the same time, the presence of exocrine dysfunction of the pancreas does not have a significant direct effect on the cIMT.

https://doi.org/10.35339/ic.7.4.159-163
PDF

References

Gubergric NB, Kazjulin AN. (2011) Metabolicheskaja pankreatologija. Doneck: Lebed'; 514 s.

Komissarenko IA. (2009) Polimorbidnost' i metabolicheskij sindrom u pozhilyh. Klinicheskaja gerontologija.; 1: 29–38.

Piciucchi M, Capurso G. (2015) Exocrine pancreatic insufficiency in diabetic patients: prevalence, mechanisms, and treatment. Int J Endocrino.

Pezzilli R, Calculli L. (2014) Pancreatic steatosis: Is it related to either obesity or diabetes mellitus? World J Diabetes; 5: 415–419.

Lew D, Afghani E, Pandol S. (2017) Chronic Pancreatitis: Current Status and Challenges for Prevention and Treatment. Dig Dis Sci; 62(7): 1702–1712

Rosso D, Carnazzo G, (2001) Atherosclerosis and pancreatic damage. Arch Gerontol Geriatr; 32(2): 95–100.

LohrJM,PanicN,(2018).Theageingpancreas:asystematicreviewoftheevidenceandanalysis of the consequences. J Intern Med; 283: 446–460 DOI:10.1111/joim.12745

Gullo, L, Stella A(1982). Cardiovascular lesions in chronic pancreatitis. Digest Dis Sci. 1982; 27: 716.

de la Iglesia D, Vallejo-Senra N, (2018). Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: A prospective, longitudinal cohort study. J Gastroenterol Hepatol [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/30156337/

Carpenter M, Sinclair H, (2016). Carotid intima media thickness and its utility as a predictor of cardiovascular disease: a review of evidence. Cardiol Rev.;24:70–75.

Liviakis L, Pogue B, Paramsothy P,( 2010). Carotid intima-media thickness for the practicing lipidologist. J Clin Lipidol;4:24–35

Polak JF, Pencina MJ, (2011). Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med. 2011;365:213–21. 2.

Baldassarre D, Hamsten A (2012). Measurements of carotid intima-media thickness and of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the IMPROVE (carotid intima media thickness [IMT] and IMT-progression as predictors of vascular events in a high risk european population) study. J Am Coll Cardiol.;60:1489–99

O'Leary DH, Polak JF, Kronmal RA, et al (1999). Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med.;340:14–22

Lorenz MW, Markus HS, Bots ML, et al. (2007) Prediction of clinical cardiovascular events with carotid intimamedia thickness: a systematic review and meta-analysis. Circulation.;115:459–467

Shoji T, Kawagishi T, Emoto M, et al. (2000) Additive impacts of diabetes and renal failure on carotid atherosclerosis. Atherosclerosis.;153:257–258.

Yoshida M, Mita T, Yamamoto R, et al (2012). Combination of the Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetes. Diabetes Care.;35:178–80. 6.

Malik S, Budof MJ, Katz R, et al (2011). Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis. Diabetes Care.;34:2285–90. 7.

Katakami N, Mita T, Gosho M, (2018). Clinical utility of carotid ultrasonography in the prediction of cardiovascular events in patients with diabetes: a combined analysis of data obtained in fve longitudinal studies. J Atheroscler Thromb;25:1053–66

Aronson D, Edelman ER (2014). Coronary artery disease and diabetes mellitus. Cardiology Clinics.; 32(3): 439–455.

Cecilia C, Wang L, (2016). Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes – Mechanisms, Management, and Clinical Considerations. Circulation; 133(24): 2459–2502

Citovs'kij MN. Statistichnij (2017), Kl3n3chnij ta morfolog3chnij aspekti vplivu cukrovogo d3abetu na stan sercevo-sudinno¿ sistemi. Naukovij v3snik Uzhgorods'kogo un3versitetu. Ser3ja: Medicina.; 1: 168–177.

Paneni F, L?scher TF. (2017) Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes. Am J Med.; 130(6S): S18–S29; Avogaro A, Fadini GP, Sesti G, Bonora E, Del Prato S. Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice. Cardiovasc Diabetol. 2016; 15: 111

Brohall G, Oden A, Fagerberg B. (2006) Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med.; 23: 609–616. 25.Gomez-Marcos MA, Recio-Rodriguez JI, et al.( 2011) Yearly evolution of organ damage markers

in diabetes or metabolic syndrome: data from the LOD-DIABETES study. Cardiovasc Diabetol.;10:90 26.Molecules. 2019 Jun; 24(11): 2062.doi: 10.3390/molecules24112062 The Multiple Faces of C-Reactive Protein-Physiological and Pathophysiological Implications in Cardiovascular Disease Magdalena

Boncler, Yi Wu and Cezary Watala. C-reactive protein in atherosclerosis: (2006) Moniek P.M. deMaat; A causal factor Elaine Paffen, Cardiovascular Research, Volume 71, Issue 1, July, Pages 30-39, https://doi.org/10.1016/ j.cardiores.2006.03.004

Steyers CM, Miller FJ (2014). Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci; 15:11324-11349 [PMID: 24968272 DOI: 10.3390/ijms150711324

Szuszkiewicz-Garcia MM, Davidson JA. (2014) Cardiovascular disease in diabetes mellitus: risk factors and medical therapy. Endocrinol Metab Clin North Am; 43: 25-40 [PMID: 24582090 DOI: 10.1016/ j.ecl.2013.09.001

Copyright for articles published in the journal is regulated by the License Agreement for the use of a scientific article in the journal, which is concluded between the author of the article (Licensor) and Kharkov National Medical University (Licensee, publisher of the journal "Inter Collegas"). The licensor grants to the Licensee a non-exclusive non-exclusive license for the use of the article (a license that does not exclude the use of the article by the Licensor and the issuance of licenses to others for use of this article) on the terms and for the period specified in the contract. The licensor (the author of the article) grants the Licensee the right to reproduce the article (publication in the journal "Inter Collegas", publication, duplication, duplication or other reproduction of the article without limiting the circulation of copies, each copy of the article must contain the name of the Licensor; Of general information, including the publication of the article in full or in part on the Internet on the journal page, the right to use the metadata of the article (titles, full names of authors, annotations, bibliography eskih materials) through the dissemination and communication to the public, processing and systematization, as well as inclusion in various databases and in-formational system).

The licensor grants the licensee the right to transfer, store and process his personal data (full name, scientific degree, academic title, place of work and position, contact information of the authors) with the purpose of including them in the database in accordance with the Law of Ukraine No. 2297 - VI "on protection of personal data" from 01.06.2010.

Personal data and metadata of the article are provided for their storage and processing in various databases and information systems, including them in analytical and statistical reporting, creating sound relationships between the objects of works of science, literature and art with personal data, etc. on unlimited territory. The licensee has the right to transfer the specified data for processing and storage to third parties provided that such a fact is notified with the provision of information about the third party (name and address) to the Licensor.